Andrea Zimmerman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Andrea Zimmerman has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Adam S. Lauring
Division of Infectious Diseases, Department of Internal Medicine, University of Michigan , Ann Arbor, MI
1 shared publication - Andrew L. Valesano
Department of Pathology, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA
1 shared publication - Kenneth J. Woodside
University of Michigan, Ann Arbor, Michigan
1 shared publication - Matthew F. Cusick
Department of Pathology, University of Michigan Medical School, United States
1 shared publication - Michael D. Olp
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin, USA
1 shared publication - Vincent A. Laufer
Department of Pathology, University of Michigan, 2800 Plymouth Rd Building 35, Ann Arbor, MI 48109, USA
1 shared publication
Latest Publications
- Open Access
HLA-C Peptide Repertoires as Predictors of Clinical Response during Early SARS-CoV-2 Infection
The human leukocyte antigen (HLA) system plays a pivotal role in the immune response to viral infections, mediating the presentation of viral peptides to T cells and influencing both the strength and specificity of the host immune response. Variations in HLA genotypes across individuals lead to differences in susceptibility to viral infection and severity of illness. This study uses observations from the early phase of the COVID-19 pandemic to explore how specific HLA class I molecules affect clinical responses to SARS-CoV-2 infection. By analyzing paired high-resolution HLA types and viral genomic sequences from 60 patients, we assess the relationship between predicted HLA class I peptide binding repertoires and infection severity as measured by the sequential organ failure assessment score. This approach leverages functional convergence across HLA-C alleles to identify relationships that may otherwise be inaccessible due to allelic diversity and limitations in sample size. Surprisingly, our findings show that severely symptomatic infection in this cohort is associated with disproportionately abundant binding of SARS-CoV-2 structural and non-structural protein epitopes by patient HLA-C molecules. In addition, the extent of overlap between a given patient’s predicted HLA-C and HLA-A peptide binding repertoires correlates with worse prognoses in this cohort. The findings highlight immunologic mechanisms linking HLA-C molecules with the human response to viral pathogens that warrant further investigation.
Open AccessHLA-C Peptide Repertoires as Predictors of Clinical Response during Early SARS-CoV-2 Infection
The human leukocyte antigen (HLA) system plays a pivotal role in the immune response to viral infections, mediating the presentation of viral peptides to T cells and influencing both the strength and specificity of the host immune response. Variations in HLA genotypes across individuals lead to differences in susceptibility to viral infection and severity of illness. This study uses observations from the early phase of the COVID-19 pandemic to explore how specific HLA class I molecules affect clinical responses to SARS-CoV-2 infection. By analyzing paired high-resolution HLA types and viral genomic sequences from 60 patients, we assess the relationship between predicted HLA class I peptide binding repertoires and infection severity as measured by the sequential organ failure assessment score. This approach leverages functional convergence across HLA-C alleles to identify relationships that may otherwise be inaccessible due to allelic diversity and limitations in sample size. Surprisingly, our findings show that severely symptomatic infection in this cohort is associated with disproportionately abundant binding of SARS-CoV-2 structural and non-structural protein epitopes by patient HLA-C molecules. In addition, the extent of overlap between a given patient’s predicted HLA-C and HLA-A peptide binding repertoires correlates with worse prognoses in this cohort. The findings highlight immunologic mechanisms linking HLA-C molecules with the human response to viral pathogens that warrant further investigation.